28 February 2008
Mr. Donald W. Jehn
Division of Scientific Advisors and Consultants,
Center for Biologics Evaluation and Research,
Food and Drug Administration (HFM-71)
1401 Rockville Pike, Rockville, MD 20892
Dear Mr. Jehn,
AABB, American Red Cross, America’s Blood Centers, and Plasma Protein Therapeutics Association wish to nominate Celso Bianco, MD, (primary representative) and Donald Baker, PhD, (alternate representative) to serve on the Blood Products Advisory Committee (BPAC) as an industry representative.
As you know we believe that the issues faced by the blood industry and the plasma industry are too diverse to be adequately represented by one individual on the BPAC. We ask that both representatives be seated for BPAC meetings so that for any particular issue the primary and alternate can decide between themselves who has the best expertise to respond.
A copy of the curriculum vitae for each nominee is attached.
If you have questions, please contact me at (919) 658-1689, or by email at firstname.lastname@example.org. Thank you for your consideration on this important issue.
M. Allene Carr-Greer
Director, Regulatory Affairs
CC: Chris Hrouda
EVP, Biomedical Services
American Red Cross
America’s Blood Centers
VP, Global Regulatory Policy
Plasma Protein Therapeutics Association